taisho pharmaceutical holdin
(4581:Tokyo Stock Exchange)
Executive Profile*
Ken UeharaManaging Director and Executive Director, Taisho Pharmaceutical Holdings Co., Ltd. |
| Age | Total Calculated Compensation | This person is connected to 14 board members in 2 different organizations across 2 different industries. See Board Relationships |
| -- | -- |
Background*
Ken Uehara serves as Managing Director and Executive Director at Taisho Pharmaceutical Holdings Co., Ltd. and Taisho Pharmaceutical Co., Ltd.
Corporate Headquarters*3-24-1, TakadaTokyo, -- 170-8655 Japan Phone: 81 3 3985 2020 Fax: -- Board Members Memberships*Managing Director and Executive Director Managing Director and Director
Education*There is no Education data available.Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| 4581:JP | ¥6,730.00 JPY | +140.00 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Joseph Jimenez MBA | Chief Executive Officer and Member of Executive Committee Novartis AG | SFr.3.4M |
| Karl-Ludwig Kley | Chairman of the Executive Board and General Partner Merck KGaA | €3.9M |
| Christopher A. Viehbacher | Chief Executive Officer, Director and Member of Strategy Committee Sanofi | €3.5M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact TAISHO PHARMACEUTICAL HOLDIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








